mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.26 |
3e-08 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
5e-05 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |